Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

AIDS

Volumn 15, Issue 16, 2001, Pages 2119-2127

  Hoffmann, Christian ^a,d,e   Tabrizian, Susanne ^b   Wolf, Eva ^a   Eggers, Christian ^c   Stoehr, Albrecht ^b   Plettenberg, Andreas ^b   Buhk, Thomas ^c   Stellbrink, Hans Jürgen ^c   Horst, Heinz August ^d   Jäger, Hans ^a   Rosenkranz, Thorsten ^b  

^a Curatorium for Immune Deficiency   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e Kuratorium für Immunschwaeche ^*  (Germany)

Author keywords

AIDS; Antiretroviral therapy; Immune recovery; Primary central nervous system lymphoma (PCNSL)

Indexed keywords

ANTIRETROVIRUS AGENT; METHOTREXATE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN RADIATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICS; SURVIVAL; SURVIVAL TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; MULTICENTER STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0035834473     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200111090-00007     Document Type: Article

References (56)

1. Changes in pathological findings at autopsy in AIDS cases for the last 15 years
2. HIV-associated brain pathology in the United Kingdom: An epidemiological study
3. The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases
4. AIDS related focal brain lesions in the era of highly active antiretroviral therapy
5. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy
6. Effect of antiretroviral therapy on recent trends in cancers among HIV infected persons
7. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
8. Non-Hodgkin's lymphoma and primary brain lymphoma as AIDS-defining illness in Western Europe, 1988-1997
9. AIDS across Europe, 1994-98: The EuroSIDA study
10. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses
11. AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases
12. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
13. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site
14. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system
15. Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma
16. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells
17. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas
18. H genes and possible implications for lymphomagenesis
19. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)
20. Primary central nervous lymphoma
21. Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: A multivariate analysis of a multi-institutional experience
22. Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome
23. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma
24. Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation
25. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus
26. Primary central nervous lymphoma in AIDS. Results of radiation therapy
27. AIDS-related central nervous system lymphomas
28. Biology and management of AIDS-associated primary CNS lymphomas
29. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy
30. Regression of AIDS-related CNS lymphoma with HAART
31. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2
32. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS
33. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group)
34. Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome
35. Primary cerebral lymphoma in AIDS. Retrospective study of 20 patients
36. Classification, pathogenesis and molecular pathology of primary CNS lymphomas
37. Evolving characteristics of AIDS-related lymphoma
38. Primary CNS lymphoma: Treatment with combined chemotherapy and radiotherapy
39. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL)
40. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
41. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and HAART in individuals infected with HIV-1
42. HAART significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy
43. Complete remission of a primary effusion lymphoma with antiretroviral therapy
44. Successful treatment of castleman's disease with HAART in two HIV-infected patients
45. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
46. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection
47. Acquired immunodeficiency syndrome-related lymphomas: Future directions
48. Transplantation-related lymphoproliferative disorder: A model for human immunodeficiency virus-related lymphomas
49. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression
50. Immunotherapy for Epstein-Barr virus-associated cancers
51. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
52. Primary brain lymphoma cell turnover differs in patients with and without AIDS: Relationships to bcl-2 expression and host cell reaction
53. Cytokine replacement in patients with HIV-1 Non-Hodgkin's lymphoma: The rationale for low-dose interleukin-2 therapy
54. Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system
55. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy
56. Neurologic sequelae of treatment of primary CNS lymphomas